In this supplement: Vehicles Matter!Cutibacterium acnes (C. acnes, formerly Propionibacterium acnes), the bacterium that lends its name to one of the most common dermatologic conditions, has been studied for decades.…
Read More
INTRODUCTIONCutibacterium acnes (C. acnes, formerly Propionibacterium acnes), the bacterium that lends its name to one of the most common dermatologic conditions, has been studied for decades. Yet science continues to…
Read More
INTRODUCTIONAcne vulgaris (AV) is a complex, inflammatory, cutaneous disorder of the pilosebaceous unit that affects 9.4% of the global population,1,2 ranking it as the eighth most prevalent disease in the…
Read More
INTRODUCTIONA cne vulgaris (AV) is a multifactorial inflammatory dermatosis of the pilosebaceous unit triggered by androgen-driven hyperseborrhea, follicular hyperkeratinization, hypercolonization of Cutibacterium acnes, and inflammation.1-3 It is the most common…
Read More
INTRODUCTIONIt is well established that acne vulgaris (AV) is associated with high patient burden and an associated adverse impact on quality of life (QoL), and it is also recommended that…
Read More
INTRODUCTIONSensitive skin (SS) is a subjective syndrome of cutaneous hyperreactivity, characterized by symptoms of redness, itching, burning, tightness, or stinging in response to innocuous stimuli.1,2 SS is common, with an…
Read More
INTRODUCTIONPsoriasis, a chronic inflammatory disease characterized by erythematous and scaly skin, is caused by hyperproliferation and differentiation of keratinocytes, which results in dysregulation of the skin barrier.1,2 Typically, a healthy…
Read More
INTRODUCTIONDefined by Kaya and Saurat in 2007, dermatoporosis is a chronic syndrome of excessive skin insufficiency/fragility.1 This loss of the skin's mechanical strength is due to modifications of the extracellular…
Read More
INTRODUCTIONAssuming comparable safety and tolerability, patients and healthcare providers strive to choose the most effective treatment for any given condition. For conditions with multiple treatment options, this requires evaluating the…
Read More
INTRODUCTION Acne vulgaris (AV) is the eighth most prevalent disease globally, and a condition reported to affect at least 50 million people in the United States.1 Because AV affects 80%…
Read More
INTRODUCTIONA recent literature review suggested that the ef fectiveness of sebaceous hyperplasia (SH) treatment was attributed to lesion severity, patient-specific qualities, and cost, rather than a specific treatment modality.1 Ambiguity…
Read More
In this supplement:Sarecycline Improves Acne Severity, Symptoms, and Psychosocial Burden in Non-nodular Acne Vulgaris: PROSES Study Background: Patient-reported outcomes (PROs) are emerging as a fundamental component of disease impact assessment in…
Read More
